Fentanyl Citrate Injection
NDC Package 0641-6249-10
Package Information
Fentanyl Citrate injection is a medication used to help relieve sudden (breakthrough) cancer pain in people who are regularly taking moderate to large amounts of opioid pain medication. This formulation utilizes a injection delivery system. Marketed by Hikma Pharmaceuticals Usa Inc., this product is identified by NDC 0641-6249 and is authorized under FDA application NDA019101.
Identification & Billing
- RxCUI: 1735003 - fentaNYL citrate 100 MCG in 2 ML Injection
- RxCUI: 1735003 - 2 ML fentanyl 0.05 MG/ML Injection
- RxCUI: 1735003 - fentanyl (as fentanyl citrate) 50 MCG/ML per 2 ML Injection
- RxCUI: 1735003 - fentanyl citrate 100 MCG per 2 ML Injection
- RxCUI: 1735007 - fentaNYL citrate 250 MCG in 5 ML Injection
Clinical Specifications
- Intramuscular - Administration within a muscle.
- Intravenous - Administration within or into a vein or veins.
Regulatory & Marketing
Hierarchy Structure
- 0641 - Hikma Pharmaceuticals Usa Inc.
- 0641-6249 - Fentanyl Citrate
- 0641-6249-10 - 10 SYRINGE, GLASS in 1 CARTON / .5 mL in 1 SYRINGE, GLASS (0641-6249-01)
- 0641-6249 - Fentanyl Citrate
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 0641-6249-10 identifies a specific commercial package of 10 syringe, glass in 1 carton / .5 ml in 1 syringe, glass (0641-6249-01) of Fentanyl Citrate, a human prescription drug labeled by Hikma Pharmaceuticals Usa Inc.. This injection is formulated for intramuscular; intravenous use and contains fentanyl citrate as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Hikma Pharmaceuticals Usa Inc. on February 01, 2023. The current certification is valid through December 31, 2027.
What are the primary indications for this medication?
This medication is used to help relieve sudden (breakthrough) cancer pain in people who are regularly taking moderate to large amounts of opioid pain medication. Fentanyl belongs to a class of drugs known as opioid analgesics. It works in the brain to change how your body feels and responds to pain. This medication should not be used to relieve mild or short-term pain (such as due to headache/migraine, dental procedures, surgery).
How is this Hikma Pharmaceuticals Usa Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 00641624910. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.